Top compounds associated with response to YARS


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA rigosertib CTRPv2 pan-cancer AAC 0.19 6e-08
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA FK866 GDSC1000 pan-cancer AAC 0.16 5e-07
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.16 6e-07
mRNA vincristine CTRPv2 pan-cancer AAC 0.16 9e-07
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.15 1e-06
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.16 2e-06
Download CSV